Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing
Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- Forbes Medi-Tech Announces Launch of Reducol(tm)-Based Products at Albert Heijn
The Netherlands's largest retailer, Albert Heijn, has launched a range of cholesterol-lowering dairy products incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The product range, marketed under the Albert Heijn private label brand, will include: a margarine spread, a spoonable yogurt, and 'original'
and 'strawberry flavor' yogurt drinks.
- TSI Health Sciences Expands European Presence, Opens Its First UK Office
Company announces the opening of its first sales and marketing office in Europe, Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
- TSI Health Sciences Expands European Presence, Opens Its First UK Office
Company announces the opening of its first sales and marketing office in Europe, Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
- TSI Health Sciences Expands European Presence, Opens Its First UK Office
Company announces the opening of its first sales and marketing office in Europe, Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
- TSI Health Sciences Expands European Presence, Opens Its First UK Office
Company announces the opening of its first sales and marketing office in Europe, Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
- TSI Health Sciences Expands European Presence, Opens Its First UK Office
Company announces the opening of its first sales and marketing office in Europe, Adrian Lindridge has been appointed sales director, Europe, and will be based out of the new office in Rochdale, Lancashire, UK.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Reliv International Names National Sales Manager For United Kingdom and Ireland Operations
Company has named Julie Sullivan to be national sales manager for its United Kingdom and Ireland operations.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Embria's EpiCor Makes International Debut
Company announces the successful launch of its high-metabolite immunogen ingredient EpiCor(tm) within the European Union and Brazil.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Tate & Lyle launches Meritab direct compressible dextrose and improved sieved dextrose grades Meritose 220 and Meritose 300
Company's European food ingredients team based in Aalst, Belgium, has launched Meritab - a new direct compressible dextrose, designed for use in confectionery products, including candy tablets, mints and energy tablets, and pharmaceutical and neutraceutical applications such as vitamin-enriched tablets.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- Cognis Completes Acquisition of Omega-3 Fish Oil Company
Company has completed the acquisition of Napro Pharma AS, a Norwegian manufacturer of high-quality omega-3 fish oils for the nutrition industry.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- ReGen Signs First Commercialisation Deal for Colostrinin(TM) with Metagenics
Company has entered into an exclusive licence agreement with Metagenics, Inc. for the commercialisation of ReGen's Colostrinin(TM) as a human nutraceutical in North America.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- Indena and Nerviano Medical Sciences Agree To Scale Up New High Potency Molecules
Companies announce a co-development agreement, under which Indena has commissioned Nerviano to handle the scale up and manufacturing of two new drug candidates for preclinical and clinical development: IDN 5404 and IDN 5243.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- UTEK Corporation and Gadot Biochemical Industries, Ltd. Announce Strategic Alliance
Companies announce that they have signed a strategic alliance agreement. In line with its strategic goal to develop innovative solutions for the fortification and supplement industry, Gadot is seeking new technologies to produce new health ingredients as well as to improve its current production processes.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- Accucaps Industries receives coveted certification from European Union (EU) for soft gel product line
Company has recently received European Union (EU) Certification enabling the company to export its products to any of the EU’s 25 member countries.
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- EAS Workshop: The Practical Implications of the EU's Nutrition and Health Claims Regulation
EAS is offering the opportunity to join a 'problem solving' workshop on the EU Regulations on nutrition and health claims and 'fortifed foods', September 13, 2006, at the Radisson Sas Royal Hotel, Brussels
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Bayer Pharma, Slovenia and Vitiva, Slovenia announced today a new broad technology collaboration. This joint venture will enable better utilization of the companies’ capabilities and reinforce their ongoing cooperation. It is based on exclusive isolation of esters from marigold flower. Bayer Pharma has registered a patent for a natural OTC product worldwide based on marigold flower extracts.
"This agreement with a leading pharmaceutical company represents a significant step for Vitiva," says Ohad Cohen, CEO of Vitiva. “Both partners, Bayer and Vitiva have made major investments to ensure the success of this venture. This collaboration will stimulate development of innovative products and will deliver new solutions for consumers who prefer to use natural ingredients – an area in which Vitiva has earned an excellent reputation. We look forward to the opportunity to work together and are confident that this agreement will lay the foundation for ongoing cooperation between Bayer Pharma and Vitiva.”
Vitiva has made repeated investments in its manufacturing facility to meet Bayer Pharma’s strict standards and requirements for high quality products and on-time delivery. “Vitiva was chosen by Bayer Pharma for its advanced technologies and facilities and its expertise in the isolation of high-value natural extracts,” says Mr. Matjaz Mohar, supply chain manager at Bayer Pharma. “This agreement acknowledges that cutting-edge natural products and intellectual property protection are the foundation for the growth and success of our industry. Vitiva, a leading global supplier of natural rosemary antioxidants, has a strong commitment to serving its customers through innovation and high quality products.”
Bayer Pharmaceuticals Corporation is part of the new Global Pharmaceutical Division, established January 1, 2006. It grew out of the former Biological Products and Pharmaceutical Division and now comprises three business units: Hematology/Cardiology, Oncology and Primary Care. Bayer HealthCare AG employed 33,800 people worldwide in 2005. Bayer Pharmaceutical Division's high-quality drug products have helped patients lead healthier lives. To continue improving human health worldwide, the company’s researchers seek innovative treatments for different diseases.
Vitiva is a dynamic, fast-growing nutraceuticals company offering natural extracts and a full range of deodorized rosemary extracts indifferent concentrations. These pure extracts are soluble in oil and water, and available in powder and liquid forms.
For more information please contact:
Mr. Ohad Cohen, CEO
Tel: +386217888738
E-mail: service@vitiva.si
www.vitiva.si
|